About This Deal

Agilent Technologies acquired e-MSion, a transaction completed in March 2023.

e-MSion operates in Life Sciences and Applied Markets, is based in Corvallis, Oregon, USA. e-MSion, an early-stage company founded by Oregon State University scientists, created the ExD cell — a compact device that adds electron-capture-dissociation (ECD) fragmentation to benchtop mass spectrometers for more comprehensive characterization of large proteins and biomolecules.

Owning the ExD cell lets Agilent embed advanced ECD capability into its benchtop LC/Q-TOF instruments and make the technology accessible to more biopharma labs, speeding biotherapeutic development.

Deal Terms

Acquirer
Agilent Technologies
Target
E-MSion
Value
Not disclosed
Date
March 2023
Type
Acquisition
Status
Official-source — no SEC filing

Transaction Details

Target HQ
Corvallis, Oregon, USA
Segment
Life Sciences and Applied Markets
Announced
March 9, 2023
Closed
March 9, 2023

In Their Words

The talented team at e-MSion has created an important technology in accelerating biopharma development.Jacob Thaysen, President, Agilent Life Sciences and Applied Markets Group

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: Press release ↗

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.